2358-54-5Relevant articles and documents
Synthesis of new fluorine-containing room temperature ionic liquids and their physical and electrochemical properties
Mei, Xinyi,Yue, Zheng,Tufts, Jim,Dunya, Hamza,Mandal, Braja K.
, p. 26 - 37 (2018)
An improved synthesis of fluorine-containing room temperature ionic liquids (FRTILs) is described. Twelve FRTILs are synthesized, in which the fluorinated cations based on N-methyl pyrrolidinium (MPy), 1-methly imidazolium (MIm) and diethylsulfide (DES) a
Polymeric 19F MRI Contrast Agents Prepared by Ring-Opening Metathesis Polymerization/Dihydroxylation
Tennie, Iris K.,Kilbinger, Andreas F. M.
, p. 10386 - 10396 (2020/12/01)
The capability of ring-opening metathesis polymerization (ROMP) to efficiently incorporate bulky monomers and conserve olefin bonds during polymerization was exploited to design water-soluble fluoropolymers, which were evaluated as potential quantitative 19F magnetic resonance imaging (MRI) contrast agents. The fluoromonomeric units comprised 3, 6, 9, or 18 magnetically equivalent fluorine atoms. Aqueous solubility was achieved through dihydroxylation of the partially unsaturated polymeric backbone and by tetraethylene glycol (TEG)-based linker incorporation, ammonium quaternization, or copolymerization.
Glucopyranosyl derivative and application thereof in medicines
-
Paragraph 0697; 0698; 0699; 0700; 0701, (2016/10/08)
The invention relates to a glucopyranosyl derivative used as a sodium-dependent glucose transporter (SGLT) inhibitor, a medicinal composition containing the derivative, and an application of the derivative and the medicinal composition in medicines, and especially relates to the glucopyranosyl derivative represented by formula (I) or a pharmaceutically acceptable salt or all stereoisomers thereof, or the medicinal composition containing the derivative, and a use of the derivative and the medicinal composition in the preparation of medicines for treating diabetes and diabetes related diseases.